Fanny Garlan
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
Papers in
-
- Cancer Genomics and Diagnostics 8
-
- Molecular Biology Techniques and Applications 2
- Single-cell and spatial transcriptomics 1
- Co-authors
- Valérie Taly (11 shared papers)Pierre Laurent‐Puig (9 shared papers)Audrey Didelot (8 shared papers)Géraldine Perkins (3 shared papers)Nicolas Pécuchet (2 shared papers)Hélène Blons (4 shared papers)Heng Lu (1 shared paper)Daniel Pietrasz (3 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Journal of Clinical Oncology (1 paper)Annals of Oncology (1 paper)Targeted Oncology (1 paper)Analytical Chemistry (1 paper)
- Partner nations
- FranceGermanySwitzerland
In The Last Decade
Fanny Garlan
11 papers receiving 627 citations
Peers
Comparison fields: 5 of 44
- Cancer Research 465
- Oncology 264
- Pathology and Forensic Medicine 102
- Pulmonary and Respiratory Medicine 150
- Molecular Biology 159
Countries citing papers authored by Fanny Garlan
This map shows the geographic impact of Fanny Garlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Garlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Garlan more than expected).
Fields of papers citing papers by Fanny Garlan
This network shows the impact of papers produced by Fanny Garlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Garlan. The network helps show where Fanny Garlan may publish in the future.
Co-authors
The 25 scholars most cited alongside Fanny Garlan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 192 | |
| 2 | 2017 | 170 | |
| 3 | 2016 | 87 | |
| 4 | 2016 | 84 | |
| 5 | 2019 | 33 | |
| 6 | 2018 | 31 | |
| 7 | 2017 | 16 | |
| 8 | 2015 | 10 | |
| 9 | 2019 | 5 | |
| 10 | 2016 | 1 | |
| 11 | 2017 | 1 |
About Fanny Garlan
Fanny Garlan is a scholar working on Cancer Research, Molecular Biology, Biomedical Engineering, Pulmonary and Respiratory Medicine and Oncology, having authored 11 papers that have together received 630 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Innovative Microfluidic and Catalytic Techniques Innovation (3 papers), Renal cell carcinoma treatment (2 papers), Microfluidic and Capillary Electrophoresis Applications (2 papers), Molecular Biology Techniques and Applications (2 papers), Single-cell and spatial transcriptomics (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Biosensors and Analytical Detection (1 paper). The work is most often cited by research in Cancer Research (465 citations), Oncology (264 citations), Pathology and Forensic Medicine (102 citations), Pulmonary and Respiratory Medicine (150 citations) and Molecular Biology (159 citations). Fanny Garlan has collaborated with scholars based in France, Germany and Switzerland. Frequent co-authors include Valérie Taly, Pierre Laurent‐Puig, Audrey Didelot, Géraldine Perkins, Nicolas Pécuchet, Hélène Blons, Heng Lu, Daniel Pietrasz, Aziz Zaanan and Solène Doat. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, Annals of Oncology, Targeted Oncology and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.